Company Analysis
Sign in

BillionToOne, Inc. (BLLN)

Nasdaq: BLLN · Services-Medical Laboratories · Menlo Park, CA · filing with the SEC since 2025
Full chart Alerts Compare
Grade6.8
◀ Past 6.7● Present 7.0▶ Future 6.7
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

9 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to BillionToOne, Inc.’s names, not what it holds today.

Patents granted
9
9 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 5 in 2024 and 2 in 2023
Applications published
17
2 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Biotechnology5
Computer technology4
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
BILLIONTOONE, INC. its own name
US, as the owner printed on each patent
9 granted
7 published
BillionToOne, Inc. its own name
named as the applicant on its applications, in US
0 granted
10 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 31, 202412,183,437Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targetsBiotechnologyBILLIONTOONE, INC.
Dec 24, 202412,176,066Target-associated molecules for characterization associated with biological targetsComputer technologyBILLIONTOONE, INC.
Aug 27, 202412,071,651Dilution tagging for quantification of biological targetsBiotechnologyBILLIONTOONE, INC.
Jul 23, 202412,043,873Molecule counting of methylated cell-free DNA for treatment monitoringBiotechnologyBILLIONTOONE, INC.
Apr 2, 202411,946,104Non-invasive prenatal testing at early stage of pregnancyBiotechnologyBILLIONTOONE, INC.
May 9, 202311,646,100Target-associated molecules for characterization associated with biological targetsComputer technologyBILLIONTOONE, INC.
Apr 18, 202311,629,381Quality control templates ensuring validity of sequencing-based assaysComputer technologyBILLIONTOONE, INC.
Dec 6, 202211,519,024Homologous genomic regions for characterization associated with biological targetsComputer technologyBILLIONTOONE, INC.
Aug 30, 202211,430,543Sequencing output determination and analysis with target-associated molecules in quantification associated with biological targetsBiotechnologyBILLIONTOONE, INC.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jul 24, 20252025/0239327LIQUID BIOPSY ASSAY FOR GENOMIC PROFILING OF CIRCULATING TUMOR DNABiotechnologyBillionToOne, Inc.
Mar 13, 20252025/0087301TARGET-ASSOCIATED MOLECULES FOR CHARACTERIZATION ASSOCIATED WITH BIOLOGICAL TARGETSComputer technologyBILLIONTOONE, INC.
Nov 28, 20242024/0392346DILUTION TAGGING FOR QUANTIFICATION OF BIOLOGICAL TARGETSBiotechnologyBILLIONTOONE, INC.
Oct 31, 20242024/0360519MOLECULE COUNTING OF METHYLATED CELL-FREE DNA FOR TREATMENT MONITORINGBiotechnologyBILLIONTOONE, INC.
Jul 11, 20242024/0229140NON-INVASIVE PRENATAL TESTING AT EARLY STAGE OF PREGNANCYBiotechnologyBILLIONTOONE, INC.
Sep 21, 20232023/0295741MOLECULE COUNTING OF METHYLATED CELL-FREE DNA FOR TREATMENT MONITORINGBiotechnologyBILLIONTOONE, INC. · patent 12,043,873 granted from it
Aug 24, 20232023/0268025TARGET-ASSOCIATED MOLECULES FOR CHARACTERIZATION ASSOCIATED WITH BIOLOGICAL TARGETSComputer technologyBILLIONTOONE, INC. · patent 12,176,066 granted from it
Jun 22, 20232023/0197202Sequencing Output Determination and Analysis with Target-Associated Molecules in Quantification Associated with Biological TargetsBiotechnologyBillionToOne, Inc. · patent 12,183,437 granted from it
Jan 19, 20232023/0015348QUALITY CONTROL TEMPLATES ENSURING VALIDITY OF SEQUENCING-BASED ASSAYSBiotechnologyBillionToOne, Inc.
Oct 27, 20222022/0340971FRAGMENT ANALYSIS FOR QUANTITATIVE DIAGNOSTICS OF BIOLOGICAL TARGETSBiotechnologyBillionToOne, Inc.
What it applied for, 2024 to 2025: Biotechnology 4 · Computer technology 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton BLLN · research, not advice